Verici DX (VRCI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

2.38p
   
  • Change Today:
    -0.040p
  • 52 Week High: 8.35p
  • 52 Week Low: 1.38p
  • Currency: UK Pounds
  • Shares Issued: 242.54m
  • Volume: 819,438
  • Market Cap: £5.77m
  • RiskGrade: 429
  • Beta: 0.25

Verici DX Overview

Verici was incorporated in April 2020 as a wholly-owned subsidiary of Renalytix AI plc ("RENX"), the AIM-quoted developer of artificial intelligence decision support and clinical management tools for improving early diagnosis, continual monitoring and drug development for kidney disease. The Company develops tests to understand how a patient is likely and may be responding to kidney transplant.
Competitors: ValiRx, e-Therapeutics, Genflow Biosciences , Oxford Biodynamics

Key Personnel

CEO: Sara Barrington
Non-Executive Chairman: Julian Baines
Senior Independent Non-Executive Director: Ian James Carruthers
Non-Executive Dir: Lorenzo Gallon, James Renwick McCullough, Erik Kristian Lium

Contact Details

Address: Avon House, 19 Stanwell Road, Penarth, Cardiff, United Kingdom, CF64 2EZ
Phone: +44 (0)29 2071 0570
Website: http://www.vericidx.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share
ISIN: GB00BM8HZD43

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Verici DX Market Data

Currency UK Pounds
Share Price 2.38p
Change Today -0.040p
% Change -1.65 %
52 Week High 8.35p
52 Week Low 1.38p
Volume 819,438
Shares Issued 242.54m
Market Cap £5.77m
Beta 0.25
RiskGrade 429

Verici DX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
30.35% below the market average30.35% below the market average30.35% below the market average30.35% below the market average30.35% below the market average
10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average10.64% below the sector average
Price Trend
92.17% below the market average92.17% below the market average92.17% below the market average92.17% below the market average92.17% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Income Not Available
Growth Not Available

Verici DX Dividends

No dividends found

Trades for 11-Apr-2025

Time Volume / Share Price
14:29 15,962 @ 1.83p
14:24 9,411 @ 2.13p
13:27 3,801 @ 1.75p
13:07 982 @ 2.14p
12:54 978 @ 2.15p

Verici DX Key Personnel

CEO Sara Barrington

Top of Page